Stock VYNE VYNE THERAPEUTICS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart VYNE Therapeutics Inc.

Equities

VYNE

US92941V3087

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-07-09 pm EDT 		5-day change 1st Jan Change
1.96 USD 0.00% Intraday chart for VYNE Therapeutics Inc. +2.08% -15.88%
Jul. 09 VYNE Therapeutics Inc. Announces Appointment of Subhashis Banerjee, M.D. as Senior Vice President of Clinical Development CI
Jul. 01 VYNE Therapeutics Inc.(NasdaqCM:VYNE) added to Russell 3000E Index CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Other Pharmaceuticals

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
VYNE THERAPEUTICS INC. Stock VYNE Therapeutics Inc.
 28.48M - - -
ELI LILLY AND COMPANY Stock Eli Lilly and Company
 827B
NOVO NORDISK A/S Stock Novo Nordisk A/S
 634B
JOHNSON & JOHNSON Stock Johnson & Johnson
 350B - - - -
MERCK & CO., INC. Stock Merck & Co., Inc.
 319B
ABBVIE INC. Stock AbbVie Inc.
 294B
  1. Stock Market
  2. Equities
  3. VYNE Stock
  4. Charts VYNE Therapeutics Inc.
  5. Sector Chart